Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - RESEARCH & DEVELOPMENT
Research & Development AKBA - Akebia Therapeutics, Inc.
63.1 M
LAST VALUE
-34.68%
2 YEAR CAGR
-26.35%
5 YEAR CAGR
19.32%
10 YEAR CAGR